Swiss packaging industry machinery and services supplier BOBST has made design changes to its digital label press, Mouvent LB701-UV, to enhance efficiency.
The enhancements include an easily accessible ink cabinet and the capacity to fit rolls of up to 600mm to make substrates more versatile.
The company has also made the screen flexible and movable in order to manage and control the machine more conveniently.
BOBST labels sales head Erik van Sloten said: “One of the hallmarks of BOBST is that we never sit still. We are always thinking of ways we can improve the customer experience.
“The way we do that is, first and foremost, by listening to our customers. The changes we have made to the Mouvent LB701-UV have come from speaking to printers and converters, understanding their needs and acting on them.
“By making the design as user-friendly as possible, we have provided the operator with the means to complete the tasks at hand.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe Mouvent LB701-UV produces digital labelling for ultra-short and medium-run label jobs with no trade-offs.
It can print labels of a 1,200 dots per inch (dpi) quality at a speed of up to 70m/min with up to six colours, as well as an optional white with 70% opacity, at 45m/min.
The company said that the machine provides the best total cost of ownership (TCO) in its category.
In October, Bobst Italia completed the renovation and expansion of its production facility in San Giorgio Monferrato, Italy.
The company added an advanced Competence Centre for machine demonstrations and research and development (R&D) trials to the facility, as well as a laboratory.
